Professional Documents
Culture Documents
DM Report
DM Report
DM Report
MBA 2023-25
DECISION MODELING
Submitted By:
Roll No. Name
MBA23003 Abhijit Mondal
MBA23008 Aman Goyal
MBA23053 Rahul
MBA23067 Tansih Bajpai
MBA23072 Vikrant Dixit
Abstract
In the context of the COVID-19 pandemic, specifically, the study "A Multi-Layer
Blood Supply Chain Configuration and Optimization under Uncertainty in
COVID-19 Pandemic" offers a thorough model for managing the blood supply
chain while taking uncertainties and interruptions into account. The suggested
methodology seeks to optimize transportation and maintenance expenses,
reduce blood loss, and choose locations strategically. It deals with erratic blood
demand, unknown blood donor quality, and unanticipated travel delays.
Validated through a real-world case study during the COVID-19 pandemic, the
model provides valuable insights for blood supply chain management. Key
findings stress the importance of considering uncertainties, balancing costs
with timely delivery, and increasing the maximum capacity of blood donation.
Contribution:
Area Member Roll No Member Name
Identification of Problems All Members
Scope, Importance & Implications MBA23003 Abhijit Mondal
Methods And processes MBA23008 Aman Goyal
TOPSIS Analysis MBA23053 Rahul
Introduction
The paper emphasizes the heightened risks associated with accidents,
disasters, and catastrophes, particularly in disaster-prone areas. Efficient blood
supply chain management is crucial in mitigating the impact of disasters, given
the need for blood transfusions resulting from injuries. Challenges such as
inadequate blood supply, delayed responses, and inefficient distribution
systems are highlighted. The study makes the case for a thorough blood supply
chain that takes into account a number of factors, with an emphasis on blood
collection, donor supply, inventory, and demand. The study directly tackles the
intricacies presented by the COVID-19 outbreak.
The problem the paper is targeting
The paper "Blood Supply Chain Management in the COVID-19 Pandemic: A
Multi-Layer Configuration and Optimization Approach" focuses on efficiently
managing the blood supply chain, especially in uncertain conditions like the
COVID-19 pandemic. The study aims to overcome challenges related to
ensuring an adequate blood supply while minimizing wastage and costs,
acknowledging the critical nature of blood as a rare and perishable substance.
Insufficient inventory risks live, while excessive donation and poor
management lead to increased costs and blood waste.
The paper addresses the critical challenge of efficiently managing the blood
supply chain in uncertain conditions, particularly during the COVID-19
pandemic. The proposed multi-level blood supply chain configuration and
optimization model offers a comprehensive and integrated approach to
management, considering various factors and uncertainties to ensure the
timely availability of blood, especially in the face of disasters like the COVID-19
pandemic.
TOPSIS Analysis
The paper proposes a mathematical model for optimizing blood supply chain
management amid the COVID-19 pandemic, considering blood product
perishability and donation-demand uncertainties. It aims to minimize total
supply chain cost and average blood product delivery time. Two solution
methods, Elastic Boundary Objectives, and modified weighted Chebyshev, are
compared, with the latter emerging as superior. The TOPSIS method selects the
best solution based on cost, responsiveness, and computational efficiency.
Validation occurs through a COVID-19 case study, revealing that integrating
mobile blood facilities alleviates delivery time concerns. Sensitivity analyses
elucidate parameter impacts on objective functions.
This study conducts sensitivity analyses, offering insights into how objective
functions respond to changes in model parameters. These analyses underscore
the robustness of the proposed model, showcasing its adaptability to dynamic
circumstances and evolving demands within the blood supply chain. The
sensitivity analyses emphasize the significance of considering uncertainties,
such as the impact of adding mobile blood facilities on delivery time.
One of the crucial insights derived from the study emphasizes the significance
of acknowledging uncertainties within the blood supply chain. Managers must
be cognizant of potential disruptions from unpredictable circumstances such as
pandemics, natural disasters, or unforeseen events. To counteract these
disruptions, managers are advised to formulate contingency plans and
strategies, including developing alternative supply sources, elevating inventory
levels, and enhancing communication and coordination among stakeholders
within the blood supply chain.
Another noteworthy finding from the study underscores the need to balance
the costs associated with the blood supply chain and the prompt delivery of
blood to hospitals. Managers should adopt optimization strategies that
minimize costs while ensuring the timely delivery of blood. This involves
judiciously selecting suitable locations, minimizing blood spoilage, and
optimizing the expenses related to blood transportation and maintenance.
Managers need to consider the impact of the coverage area on the
performance of the blood supply chain, ensuring a harmonious balance
between the coverage area and the timely delivery of blood to hospitals.
The study highlights the critical need to expand the maximum blood donation
volume achievable by donors incrementally. This strategic adaptation,
implemented without impacting cost efficiency or average blood delivery time,
is essential to bolster the blood supply chain network in the face of the COVID-
19 pandemic. By raising the upper limit of blood donations, the average shelf
life of blood inventory can be extended, thereby significantly enhancing the
timely delivery of blood to hospitals. This essential step can help ensure
sufficient blood reserves are readily available for needy patients, ultimately
improving healthcare outcomes.